RGEBX
Price
$74.89
Change
-$0.91 (-1.20%)
Updated
Jun 13 closing price
Net Assets
306.22B
VHIAX
Price
$38.33
Change
-$0.43 (-1.11%)
Updated
Jun 13 closing price
Net Assets
21.18B
Interact to see
Advertisement

RGEBX vs VHIAX

Header iconRGEBX vs VHIAX Comparison
Open Charts RGEBX vs VHIAXBanner chart's image
American Funds Growth Fund of Amer R2E
Price$74.89
Change-$0.91 (-1.20%)
VolumeN/A
Net Assets306.22B
JPMorgan Growth Advantage A
Price$38.33
Change-$0.43 (-1.11%)
VolumeN/A
Net Assets21.18B
RGEBX vs VHIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RGEBX vs. VHIAX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGEBX is a Buy and VHIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 306B vs. VHIAX (21.2B). RGEBX (0.00) and VHIAX (0.00) have matching dividends . RGEBX was incepted earlier than VHIAX: RGEBX (11 years) vs VHIAX (26 years). RGEBX (1.09) and VHIAX (1.08) have similar cost to investors . VHIAX is a more actively managed with annual turnover of: 28.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than VHIAX: RGEBX (250) vs VHIAX (1000). RGEBX annual gain was more profitable for investors over the last year : 7.68 vs. VHIAX (5.91). VHIAX return over 5 years is better than : 59.84 vs. RGEBX (45.42).
RGEBXVHIAXRGEBX / VHIAX
Total Expense Ratio1.090.99110%
Annual Report Gross Expense Ratio1.091.08101%
Fund Existence11 years26 years-
Gain YTD4.8291.483326%
Front LoadN/A5%-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets306B21.2B1,443%
Annual Yield % from dividends0.000.00-
Returns for 1 year7.685.91130%
Returns for 3 years51.0172.4270%
Returns for 5 years45.4259.8476%
Returns for 10 years65.87141.5247%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APGE44.482.62
+6.26%
Apogee Therapeutics
VVOS2.140.01
+0.47%
Vivos Therapeutics
SJM95.72-1.65
-1.69%
JM Smucker Company (The)
ELVA3.38-0.17
-4.79%
Electrovaya
NNDM1.44-0.12
-7.69%
Nano Dimension Ltd